Short Interest in Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDF) Grows By 300.0%

Santhera Pharmaceuticals Holding AG (OTCMKTS:SPHDFGet Free Report) was the target of a large increase in short interest during the month of February. As of February 28th, there was short interest totalling 3,600 shares, an increase of 300.0% from the February 13th total of 900 shares. Based on an average trading volume of 0 shares, the short-interest ratio is currently ∞ days.

Santhera Pharmaceuticals Price Performance

Shares of SPHDF stock opened at $16.00 on Friday. Santhera Pharmaceuticals has a twelve month low of $16.00 and a twelve month high of $16.00. The stock’s 50 day simple moving average is $9.95 and its 200 day simple moving average is $10.73.

Santhera Pharmaceuticals Company Profile

(Get Free Report)

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes Vamorolone, which is being developed for the treatments of Duchenne muscular dystrophy (DMD).

Recommended Stories

Receive News & Ratings for Santhera Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Santhera Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.